Fecal Calprotectin Collection Protocol

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

August 23, 2018

Study Completion Date

August 23, 2018

Conditions
Inflammatory Bowel DiseasesIrritable Bowel SyndromeUlcerative ColitisCrohn DiseaseIndeterminate ColitisChronic DiarrheaCeliac DiseaseDiverticulitisAbdominal PainDistensionWeight LossFood IntoleranceConstipation
Interventions
DIAGNOSTIC_TEST

Stool collection

Stool sample collected by a subject who have been diagnosed with IBD, IBS or other GI disorder. The stool sample is tested in a laboratory where fecal calprotectin levels are quantified.

Trial Locations (13)

28801

One (1) Location in North Carolina, Asheville

29615

One (1) Location in Greenville, SC, Greenville

30342

One (1) Location in Atlanta, GA, Atlanta

32086

One (1) Location in St. Augustine, FL, Saint Augustine

32751

One (1) Location in Maitland, FL, Maitland

33134

One (1) Location in Miami, Florida, Miami

One (1) Location in New York, New York, New York

33319

One (1) Location in Lauderdale Lakes, FL, Lauderdale Lakes

36305

One (1) Location in Dothan, Alabama, Dothan

55455

One (1) Location in Minneapolis, MN, Minneapolis

72117

One (1) Facility in Arkansas, Little Rock

80907

One (1) Location in Colorado Springs, Colorado, Colorado Springs

91345

One (1) Location in California, Mission Hills

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DiaSorin Inc.

INDUSTRY

NCT03143517 - Fecal Calprotectin Collection Protocol | Biotech Hunter | Biotech Hunter